Author

J.-Y. Fang

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:metagenomics· 1 Assay:proteomics· 1 Approach:statistical model· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

C. Li· 1 shared C. Zhou· 1 shared H. Wang· 1 shared H. Yao· 1 shared J. Xu· 1 shared J.-W. Deng· 1 shared S.-Y. Pan· 1 shared Y.-L. Zhou· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

C. Li

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The effects of pks+ Escherichia coli and bile acid in colorectal tumorigenesis among people with cholelithiasis or cholecystectomy.

S.-Y. Pan, C. Zhou, J.-W. Deng, Y.-L. Zhou, Z.-H. Liu, J.-Y. Fang

This study investigates the association between pks+ Escherichia coli, bile acid metabolism, and colorectal neoplasia in patients with cholelithiasis or cholecystectomy, finding enrichment of pks+ E. coli and links to colorectal adenoma and cancer.

bioRxiv · Dec 7, 2022 · PreprintMicrobiology

Repurposing screen identifies Amlodipine as an inducer of PD-L1 degradation and antitumor immunity

C. Li, H. Yao, H. Wang, J.-Y. Fang, J. Xu

This study identifies amlodipine as a drug that reduces PD-L1 expression and enhances antitumor immunity by blocking calcium flux and autophagic degradation of PD-L1.

bioRxiv · May 26, 2020Cancer Biology